DE69939470D1 - Verfahren zur herstellung von cyclosporin-derivaten - Google Patents

Verfahren zur herstellung von cyclosporin-derivaten

Info

Publication number
DE69939470D1
DE69939470D1 DE69939470T DE69939470T DE69939470D1 DE 69939470 D1 DE69939470 D1 DE 69939470D1 DE 69939470 T DE69939470 T DE 69939470T DE 69939470 T DE69939470 T DE 69939470T DE 69939470 D1 DE69939470 D1 DE 69939470D1
Authority
DE
Germany
Prior art keywords
cyclosporin
preparation
preparing
optionally
cyclosporin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939470T
Other languages
English (en)
Inventor
Christian Viskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69939470D1 publication Critical patent/DE69939470D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69939470T 1998-06-22 1999-06-21 Verfahren zur herstellung von cyclosporin-derivaten Expired - Lifetime DE69939470D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807846A FR2780061B1 (fr) 1998-06-22 1998-06-22 Nouveau procede de preparation de derives de cyclosporine
PCT/FR1999/001480 WO1999067280A1 (fr) 1998-06-22 1999-06-21 Nouveau procede de preparation de derives de cyclosporine

Publications (1)

Publication Number Publication Date
DE69939470D1 true DE69939470D1 (de) 2008-10-16

Family

ID=9527672

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939470T Expired - Lifetime DE69939470D1 (de) 1998-06-22 1999-06-21 Verfahren zur herstellung von cyclosporin-derivaten

Country Status (8)

Country Link
US (3) US7226905B2 (de)
EP (1) EP1098903B1 (de)
JP (1) JP4224213B2 (de)
AT (1) ATE407140T1 (de)
AU (1) AU4270099A (de)
DE (1) DE69939470D1 (de)
FR (1) FR2780061B1 (de)
WO (1) WO1999067280A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939335D1 (de) 1998-12-30 2008-09-25 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
IL150601A (en) * 2001-07-19 2010-06-30 Organon Nv Process for rapid synthesis of peptides within a solution using the back of an activated carboxyl component and destruction of the residual activated carboxyl component
TWI243826B (en) * 2001-07-19 2005-11-21 Akzo Nobel Nv Process for the preparation of peptides
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
KR20040039622A (ko) * 2002-11-04 2004-05-12 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
KR20070009674A (ko) * 2004-04-08 2007-01-18 노파르티스 아게 대뇌 허혈 및 뇌와 척수 상해에서의 ｎｉｍ８１１
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
NZ554514A (en) * 2004-10-01 2010-10-29 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
NZ567262A (en) 2005-09-30 2011-12-22 Scynexis Inc Cyclosporin derivatives and their use for the treatment and prevention of hepatitis C infection
ATE498630T1 (de) 2005-09-30 2011-03-15 Scynexis Inc Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
WO2007136759A2 (en) 2006-05-19 2007-11-29 Scynexis, Inc. Method for the treatment and prevention of ocular disorders
EP2027761A1 (de) * 2006-06-02 2009-02-25 Claude Annie Perrichon Verwaltung von aktieven elektronen
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
US9090671B2 (en) 2008-06-06 2015-07-28 Scynexis, Inc. Macrocyclic peptides
EP2376524B1 (de) 2008-12-31 2017-03-15 Cypralis Limited Derivate von cyclosporin a
CA2763207A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
CA2785978A1 (en) 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
EP3461835A1 (de) 2010-12-15 2019-04-03 ContraVir Pharmaceuticals, Inc. An den aminosäuren 1 und 3 modifizierte cyclosporin-analog-moleküle
CN104603146B (zh) 2012-09-29 2018-01-02 诺华股份有限公司 环肽类化合物及其作为药物的用途
US10227877B2 (en) 2016-08-18 2019-03-12 General Electric Company Cooling circuit for a multi-wall blade
WO2020037530A1 (en) * 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (de) * 1985-03-11 1992-07-29 Sandoz Ag Cyclosporine
JPH0267244A (ja) * 1988-09-01 1990-03-07 Wako Pure Chem Ind Ltd β−ヒドロキシ脂肪酸の製法
US4937355A (en) * 1989-01-17 1990-06-26 E. R. Squibb & Sons, Inc. Process for preparing (trans)-4-substituted-dl-proline derivatives
JPH0793927B2 (ja) * 1990-11-02 1995-10-11 富士通株式会社 超音波カラードプラ診断装置
EP0484281B2 (de) 1990-11-02 2000-11-22 Novartis AG Zyklosporine
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine

Also Published As

Publication number Publication date
US20010025025A1 (en) 2001-09-27
EP1098903A1 (de) 2001-05-16
AU4270099A (en) 2000-01-10
WO1999067280A1 (fr) 1999-12-29
US7226905B2 (en) 2007-06-05
FR2780061B1 (fr) 2001-09-07
US20070213260A1 (en) 2007-09-13
US7678766B2 (en) 2010-03-16
US20100173838A1 (en) 2010-07-08
EP1098903B1 (de) 2008-09-03
JP2002518519A (ja) 2002-06-25
FR2780061A1 (fr) 1999-12-24
JP4224213B2 (ja) 2009-02-12
ATE407140T1 (de) 2008-09-15

Similar Documents

Publication Publication Date Title
DE69939470D1 (de) Verfahren zur herstellung von cyclosporin-derivaten
DE69916435D1 (de) Verfahren zur verbesserung der ductilität von nitinol
ATE324866T1 (de) Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid
DE602005021684D1 (de) Verfahren zur herstellung von pimecrolimus
DE59611374D1 (de) Verfahren zur Herstellung von D,L-Methionin oder dessen Salz
IL189629A0 (en) Compositions containing human ctla-4 antibodies
DE59606355D1 (de) Verfahren zur Herstellung von chlorfunktionellen Organosilanen armen bzw. freien aminofunktionellen Organosilanen
DE69918799D1 (de) Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE59204480D1 (de) Verfahren zur Herstellung von tert.-Butoxycarbonyl-Gruppen tragenden organischen Verbindungen.
ATE278441T1 (de) Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind
DE69905273T2 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
DE3586831T2 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE69202115D1 (de) Verfahren zur Darstellung von 1,2-Naphtho-Chinondiazido-5-Sulfonylchlorid.
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
DE69418260D1 (de) Verfahren zur Herstellung von L-3,4-Dihydroxyphenylalanin
DE60130524D1 (de) Verfahren zur elektrochemischen Behandlung von Artikeln
DE3586371T2 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
DE69616913T2 (de) Verfahren zur Herstellung von 3,7-Dimethyl-5,7-octadien-1-ol oder Rosenoxid
DE69707825T2 (de) Verfahren zur Herstellung von alicyclischen Hydrazin-derivaten.
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE69617685D1 (de) Zusammensetzung und verfahren zur stabilisierung von radiomarkierten organischen verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition